Xtant Medical Holdings (XTNT) FCF Margin (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of FCF Margin data on file, last reported at 12.58% in Q3 2025.

• On a quarterly basis, FCF Margin rose 2626.0% year-over-year to 12.58% in Q3 2025; TTM through Sep 2025 was 3.89%, a 1906.0% increase from a year earlier, with the FY2024 full-year figure at 13.65%, down 164.0% from the prior year.
• FCF Margin for Q3 2025 stood at 12.58%, up from 2.57% in the prior quarter.
• Over the last five years, FCF Margin for XTNT reached as high as 12.58% in Q3 2025 and fell as low as 23.42% in Q1 2024.
• Historically, FCF Margin has averaged 8.14% across 5 years, with a median of 11.49% in 2022.
• Across the five-year window, FCF Margin tumbled 1644 bps in 2022 and surged 2626 bps in 2025, its largest moves.
• Year by year, FCF Margin stood at 1.44% in 2021, then plunged by 1140 bps to 17.88% in 2022, then jumped by 75 bps to 4.55% in 2023, then jumped by 100 bps to 0.02% in 2024, then soared by 56713 bps to 12.58% in 2025.
• Per Business Quant data, the three most recent FCF Margin figures were 12.58% in Q3 2025, 2.57% in Q2 2025, and 0.26% in Q1 2025.